Christine C Esau

Christine C Esau

UNVERIFIED PROFILE

Are you Christine C Esau?   Register this Author

Register author
Christine C Esau

Christine C Esau

Publications by authors named "Christine C Esau"

Are you Christine C Esau?   Register this Author

15Publications

332Reads

36Profile Views

A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid distribution away from the liver.

Hepatology 2015 Jan 24;61(1):141-52. Epub 2014 Nov 24.

Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California San Francisco, San Francisco, CA; Department of Pathology, University of California San Francisco, San Francisco, CA; Liver Center, University of California San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.27379DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465779PMC
January 2015

Let-7 coordinately suppresses components of the amino acid sensing pathway to repress mTORC1 and induce autophagy.

Cell Metab 2014 Oct;20(4):626-38

Department of Pediatrics, University of California, San Diego, La Jolla, CA 92093, USA; Department of Neurosciences, University of California, San Diego, La Jolla, CA 92093, USA; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA; Department of Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92093, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA 92093, USA; Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA 92093, USA; Rady Children's Hospital, San Diego, CA 92123, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cmet.2014.09.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245205PMC
October 2014

Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr-/- mice--brief report.

Arterioscler Thromb Vasc Biol 2013 Aug 23;33(8):1973-7. Epub 2013 May 23.

Department of Medicine, Leon H Charney Division of Cardiology and Cell Biology and the Marc and Ruti Bell Vascular Biology and Disease Program, New York University School of Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/ATVBAHA.113.301732
Publisher Site
http://dx.doi.org/10.1161/ATVBAHA.113.301732DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157595PMC
August 2013

An SREBP-responsive microRNA operon contributes to a regulatory loop for intracellular lipid homeostasis.

Cell Metab 2013 Jul;18(1):51-61

Metabolic Signaling and Disease Program and Diabetes and Obesity Center, Sanford-Burnham Medical Research Institute, Orlando, Florida 32827, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cmet.2013.06.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3740797PMC
July 2013

MyomiR-133 regulates brown fat differentiation through Prdm16.

Nat Cell Biol 2012 Dec;14(12):1330-5

Institute of Molecular Health Sciences, ETH Zurich, Schafmattstrasse 22, HPL H36, 8093 Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/ncb2612
Publisher Site
http://dx.doi.org/10.1038/ncb2612DOI Listing
December 2012

Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.

Nature 2011 Oct 19;478(7369):404-7. Epub 2011 Oct 19.

Marc and Ruti Bell Vascular Biology and Disease Program, Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature10486DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235584PMC
October 2011

Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

J Clin Invest 2011 Jul 6;121(7):2921-31. Epub 2011 Jun 6.

Marc and Ruti Bell Vascular Biology and Disease Program, Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI57275DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223840PMC
July 2011

MicroRNA-122 modulates the rhythmic expression profile of the circadian deadenylase Nocturnin in mouse liver.

PLoS One 2010 Jun 22;5(6):e11264. Epub 2010 Jun 22.

Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011264PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889834PMC
June 2010

MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators.

Mol Cell Biol 2008 Sep 30;28(17):5369-80. Epub 2008 Jun 30.

Center of Neurologic Diseases, Brigham and Women's Hospital, 4 Blackfan Circle, HIM 758, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/MCB.00479-08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2519720PMC
September 2008

Inhibition of microRNA with antisense oligonucleotides.

Authors:
Christine C Esau

Methods 2008 Jan;44(1):55-60

Isis Pharmaceuticals and Regulus Therapeutics, 1896 Rutherford Road, Carlsbad, CA 92008, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymeth.2007.11.001DOI Listing
January 2008

Therapeutic potential for microRNAs.

Adv Drug Deliv Rev 2007 Mar 16;59(2-3):101-14. Epub 2007 Mar 16.

Isis Pharmaceuticals, 1896 Rutherford Road, Carlsbad, California 92008, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.addr.2007.03.007DOI Listing
March 2007